Stay updated on EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The website revision identifier in the footer changed from v3.7.2 to v3.8.0.
    Difference
    0.1%
    Check dated 2026-11-02T15:51:08.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    A notice was added announcing NIH website changes and explaining that the agency is transitioning from the term “Artificial Intelligence” to “Super Intelligence”.
    Difference
    0.7%
    Check dated 2026-10-26T14:25:22.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site revision changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:11:10.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The site revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:28:18.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Added a new revision entry v3.7.0 to the study record history. The previous revision v3.6.6 was removed from the history.
    Difference
    0.1%
    Check dated 2026-09-21T22:17:56.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    A new revision (v3.6.6) was added to the study's history, replacing the previous revision (v3.6.5) and indicating an update to the record on ClinicalTrials.gov.
    Difference
    0.1%
    Check dated 2026-08-31T17:37:52.000Z thumbnail image

Stay in the know with updates to EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the EUCROSS: Crizotinib in ROS1+ Lung Cancer Clinical Trial page.